Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase (vol 8, pg 762, 2020)

被引：1
|
作者：
Pivonello, R.
Fleseriu, M.
Newell-Price, J.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 09期
关键词：
D O I：
10.1016/S2213-8587(20)30275-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e4 / e4
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of eculizumab in Guillain-Barre syndrome: a multicentre, double-blind, randomised phase 2 trial
    Misawa, Sonoko
    Kuwabara, Satoshi
    Sato, Yasunori
    Yamaguchi, Nobuko
    Nagashima, Kengo
    Katayama, Kanako
    Sekiguchi, Yukari
    Iwai, Yuta
    Amino, Hiroshi
    Suichi, Tomoki
    Yokota, Takanori
    Nishida, Yoichiro
    Kanouchi, Tadashi
    Kohara, Nobuo
    Kawamoto, Michi
    Ishii, Junko
    Kuwahara, Motoi
    Suzuki, Hidekazu
    Hirata, Koichi
    Kokubun, Norito
    Masuda, Ray
    Kaneko, Juntaro
    Yabe, Ichiro
    Sasaki, Hidenao
    Kaida, Ken-ichi
    Takazaki, Hiroshi
    Suzuki, Norihiro
    Suzuki, Shigeaki
    Nodera, Hiroyuki
    Matsui, Naoko
    Tsuji, Shoji
    Koike, Haruki
    Yamasaki, Ryo
    Kusunoki, Susumu
    LANCET NEUROLOGY, 2018, 17 (06) : 519 - 529
  • [32] Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial
    Hanauer, Stephen
    Liedert, Bernd
    Balser, Sigrid
    Brockstedt, Ekkehard
    Moschetti, Viktoria
    Schreiber, Stefan
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (10): : 816 - 825
  • [33] Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Mori, Masaaki
    Miyamae, Takoko
    Aihara, Yukoh
    Takei, Shuji
    Iwata, Naomi
    Umebayashi, Hiroaki
    Murata, Takuji
    Miyoshi, Mari
    Tomiita, Minako
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    LANCET, 2008, 371 (9617) : 998 - 1006
  • [34] Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (vol 23, pg 393, 2024)
    Mercuri, E.
    Vilchez, J. J.
    Boespflug-Tanguy, O.
    LANCET NEUROLOGY, 2024, 23 (06) : E10 - E10
  • [35] Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
    Mignot, Emmanuel
    Mayleben, David
    Fietze, Ingo
    Leger, Damien
    Zammit, Gary
    Bassetti, Claudio L. A.
    Pain, Scott
    Kinter, Dalma Seboek
    Roth, Thomas
    LANCET NEUROLOGY, 2022, 21 (02) : 125 - 139
  • [36] Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
    Sheng, Xinan
    Ye, DingWei
    Zhou, Aiping
    Yao, Xin
    Luo, Hong
    He, Zhisong
    Wang, Zengjun
    Zhao, Yingchao
    Ji, Zhigang
    Zou, Qing
    He, Chaohong
    Guo, Jianming
    Tu, Xinhua
    Liu, Ziling
    Shi, Benkang
    Liu, Ben
    Chen, Peng
    Wei, Qiang
    Hu, Zhiquan
    Zhang, Yanqiao
    Jiang, Kui
    Zhou, Fangjian
    Wu, Dapeng
    Fu, Cheng
    Li, Xingya
    Wu, Bin
    Wang, Lijie
    Qin, Shukui
    Li, Gang
    Liu, Yunpeng
    Guo, Hongqian
    Chen, Kehe
    Zhang, Dahong
    Wang, Gongxian
    Ding, Lieming
    Wang, Yang
    Yuan, Xiaobin
    Guo, Jun
    EUROPEAN JOURNAL OF CANCER, 2023, 178 : 205 - 215
  • [37] Radiotherapy for Ledderhose disease: Results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial
    de Haan, Anneke
    van Nes, Johanna G. H.
    Kolff, M. Willemijn
    van der Toorn, Peter-Paul
    Westenberg, A. Helen
    van der Vegt, Annelies E.
    Groen, Henk
    Overbosch, Jelle
    van der Laan, Hans Paul
    Werker, Paul M. N.
    Langendijk, Johannes A.
    Steenbakkers, Roel J. H. M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 185
  • [38] Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
    Brunner, Hermine I.
    Ruperto, Nicolino
    Zuber, Zbigniew
    Keane, Caroline
    Harari, Olivier
    Kenwright, Andrew
    Lu, Peng
    Cuttica, Ruben
    Keltsev, Vladimir
    Xavier, Ricardo M.
    Calvo, Inmaculada
    Nikishina, Irina
    Rubio-Perez, Nadina
    Alexeeva, Ekaterina
    Chasnyk, Vyacheslav
    Horneff, Gerd
    Opoka-Winiarska, Violetta
    Quartier, Pierre
    Silva, Clovis A.
    Silverman, Earl
    Spindler, Alberto
    Baildam, Eileen
    Luz Gamir, M.
    Martin, Alan
    Rietschel, Christoph
    Siri, Daniel
    Smolewska, Elzbieta
    Lovell, Daniel
    Martini, Alberto
    De Benedetti, Fabrizio
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1110 - 1117
  • [39] Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
    King, Brett
    Zhang, Xingqi
    Harcha, Walter Gubelin
    Szepietowski, Jacek C.
    Shapiro, Jerry
    Lynde, Charles
    Mesinkovska, Natasha A.
    Zwillich, Samuel H.
    Napatalung, Lynne
    Wajsbrot, Dalia
    Fayyad, Rana
    Freyman, Amy
    Mitra, Debanjali
    Purohit, Vivek
    Sinclair, Rodney
    Wolk, Robert
    LANCET, 2023, 401 (10387) : 1518 - 1529
  • [40] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
    Armstrong, Matthew James
    Gaunt, Piers
    Aithal, Guruprasad P.
    Barton, Darren
    Hull, Diana
    Parker, Richard
    Hazlehurst, Jonathan M.
    Guo, Kathy
    Abouda, George
    Aldersley, Mark A.
    Stocken, Deborah
    Gough, Stephen C.
    Tomlinson, Jeremy W.
    Brown, Rachel M.
    Huebscher, Stefan G.
    Newsome, Philip N.
    LANCET, 2016, 387 (10019) : 679 - 690
12345